In a potential ray of hope for thousands of people with undiagnosed conditions, the Japan Agency for Medical Research and Development has launched a project to refer such patients to a centralized network of specialists for genome analysis.

The Initiative on Rare and Undiagnosed Diseases (IRUD), launched Wednesday, is designed to help people suffering from medically unidentified conditions find a diagnosis and receive expert consultation, taking advantage of advances in genetic testing techniques.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.